These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 17176481)
41. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. Craib KJ; Spittal PM; Wood E; Laliberte N; Hogg RS; Li K; Heath K; Tyndall MW; O'Shaughnessy MV; Schechter MT CMAJ; 2003 Jan; 168(1):19-24. PubMed ID: 12515780 [TBL] [Abstract][Full Text] [Related]
42. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. Palepu A; Tyndall MW; Li K; Yip B; O'Shaughnessy MV; Schechter MT; Montaner JS; Hogg RS J Urban Health; 2003 Dec; 80(4):667-75. PubMed ID: 14709714 [TBL] [Abstract][Full Text] [Related]
43. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Wood E; Kerr T; Small W; Li K; Marsh DC; Montaner JS; Tyndall MW CMAJ; 2004 Sep; 171(7):731-4. PubMed ID: 15451834 [TBL] [Abstract][Full Text] [Related]
44. Estimated drug overdose deaths averted by North America's first medically-supervised safer injection facility. Milloy MJ; Kerr T; Tyndall M; Montaner J; Wood E PLoS One; 2008 Oct; 3(10):e3351. PubMed ID: 18839040 [TBL] [Abstract][Full Text] [Related]
45. Recent incarceration independently associated with syringe sharing by injection drug users. Wood E; Li K; Small W; Montaner JS; Schechter MT; Kerr T Public Health Rep; 2005; 120(2):150-6. PubMed ID: 15842116 [TBL] [Abstract][Full Text] [Related]
47. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Kerr T; Marsh D; Li K; Montaner J; Wood E Drug Alcohol Depend; 2005 Dec; 80(3):329-35. PubMed ID: 15964714 [TBL] [Abstract][Full Text] [Related]
48. Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Wood E; Tyndall MW; Lai C; Montaner JS; Kerr T Subst Abuse Treat Prev Policy; 2006 May; 1():13. PubMed ID: 16722550 [TBL] [Abstract][Full Text] [Related]
49. Prevalence and correlates of jugular injections among injection drug users. Hoda Z; Kerr T; Li K; Montaner JS; Wood E Drug Alcohol Rev; 2008 Jul; 27(4):442-6. PubMed ID: 18584397 [TBL] [Abstract][Full Text] [Related]
50. Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort. Cox J; Maurais E; Hu L; Moodie EE; Law S; Bozinoff N; Potter M; Rollet K; Hull M; Tyndall M; Cooper C; Gill J; Saeed S; Klein MB; Drug Alcohol Depend; 2014 Apr; 137():121-8. PubMed ID: 24559606 [TBL] [Abstract][Full Text] [Related]
51. Factors associated with geographic migration among a cohort of injection drug users. Rachlis BS; Hogg RS; Wood E; Li K; Kerr T Health Place; 2008 Sep; 14(3):536-43. PubMed ID: 18410717 [TBL] [Abstract][Full Text] [Related]
52. Key findings from a national enhanced HIV surveillance system: 2010 - 2012. Tarasuk J; Ogunnaike-Cooke S; Archibald C; MacLean R; Bennett R; Kim J; Malloch L; Can Commun Dis Rep; 2014 Nov; 40(18):397-407. PubMed ID: 29769871 [TBL] [Abstract][Full Text] [Related]
53. The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility. Wood E; Kerr T; Tyndall MW; Montaner JS Int J Drug Policy; 2008 Jun; 19(3):220-5. PubMed ID: 18551754 [TBL] [Abstract][Full Text] [Related]
54. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study. Alavi M; Grebely J; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ; Clin Infect Dis; 2013 Aug; 57 Suppl 2():S62-9. PubMed ID: 23884068 [TBL] [Abstract][Full Text] [Related]
55. Increasing use and associated harms of crystal methamphetamine injection in a Canadian setting. Fairbairn N; Kerr T; Buxton JA; Li K; Montaner JS; Wood E Drug Alcohol Depend; 2007 May; 88(2-3):313-6. PubMed ID: 17141427 [TBL] [Abstract][Full Text] [Related]
56. Difficulty accessing syringes and syringe borrowing among injection drug users in Bangkok, Thailand. Kerr T; Fairbairn N; Hayashi K; Suwannawong P; Kaplan K; Zhang R; Wood E Drug Alcohol Rev; 2010 Mar; 29(2):157-61. PubMed ID: 20447223 [TBL] [Abstract][Full Text] [Related]
57. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668 [TBL] [Abstract][Full Text] [Related]
58. Hospital utilization and costs in a cohort of injection drug users. Palepu A; Tyndall MW; Leon H; Muller J; O'Shaughnessy MV; Schechter MT; Anis AH CMAJ; 2001 Aug; 165(4):415-20. PubMed ID: 11531049 [TBL] [Abstract][Full Text] [Related]
59. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408 [TBL] [Abstract][Full Text] [Related]
60. The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities. Mehrabadi A; Craib KJ; Patterson K; Adam W; Moniruzzaman A; Ward-Burkitt B; Schechter MT; Spittal PM; Int J Drug Policy; 2008 Apr; 19(2):159-68. PubMed ID: 17870461 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]